DK3242957T3 - Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme - Google Patents

Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme Download PDF

Info

Publication number
DK3242957T3
DK3242957T3 DK16700202.1T DK16700202T DK3242957T3 DK 3242957 T3 DK3242957 T3 DK 3242957T3 DK 16700202 T DK16700202 T DK 16700202T DK 3242957 T3 DK3242957 T3 DK 3242957T3
Authority
DK
Denmark
Prior art keywords
metabolic
diseases
treat
methods
same
Prior art date
Application number
DK16700202.1T
Other languages
English (en)
Inventor
Vos Willem Meindert De
Thi Phuong Nam Bui
Original Assignee
Univ Wageningen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wageningen filed Critical Univ Wageningen
Application granted granted Critical
Publication of DK3242957T3 publication Critical patent/DK3242957T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/1203Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK16700202.1T 2015-01-09 2016-01-08 Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme DK3242957T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15150701 2015-01-09
PCT/EP2016/050310 WO2016110585A1 (en) 2015-01-09 2016-01-08 Bacteria-comprising compositions and methods of using the same for treating and/or preventing gastrointestinal, metabolic and/or other diseases

Publications (1)

Publication Number Publication Date
DK3242957T3 true DK3242957T3 (da) 2020-06-02

Family

ID=52434520

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16700202.1T DK3242957T3 (da) 2015-01-09 2016-01-08 Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme

Country Status (13)

Country Link
US (2) US11452746B2 (da)
EP (1) EP3242957B1 (da)
KR (1) KR20170103920A (da)
CN (1) CN107405369A (da)
AU (1) AU2016205975B2 (da)
BR (1) BR112017014649A2 (da)
CA (1) CA2973285C (da)
DK (1) DK3242957T3 (da)
ES (1) ES2796355T3 (da)
PL (1) PL3242957T3 (da)
RU (1) RU2017126666A (da)
SG (1) SG11201705450SA (da)
WO (1) WO2016110585A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2964480A1 (en) 2014-10-31 2016-05-06 Whole Biome Inc. Methods and compositions relating to microbial treatment and diagnosis of disorders
KR20170103920A (ko) 2015-01-09 2017-09-13 바게닝겐 유니버시테이트 위장관, 대사성 및/또는 기타 질환의 치료 및/또는 예방을 위한 박테리아-함유 조성물 및 이의 사용 방법
CN108697742A (zh) 2016-02-25 2018-10-23 卡勒斯制药有限公司 用于预防和/或治疗维生素b12缺乏症的组合物和方法
JP2020532515A (ja) 2017-08-30 2020-11-12 ペンデュラム セラピューティクス, インコーポレイテッド マイクロバイオーム関連障害の処置のための方法および組成物
US11850270B2 (en) 2017-12-04 2023-12-26 The BioCollective, LLC Probiotics and methods of use
EP3823651A4 (en) 2018-07-19 2022-04-27 Pendulum Therapeutics, Inc. METHODS AND COMPOSITIONS FOR MICROBIAL TRANSPLANTATION
FR3085963A1 (fr) * 2018-09-19 2020-03-20 Novolyze Composition seche de microorganismes modeles
NL2024569B1 (en) * 2019-12-24 2021-09-06 Univ Wageningen Bacterium comprising myo-inositol to propionate pathway
RU2734718C1 (ru) * 2019-12-31 2020-10-22 Федеральное государственное бюджетное научное учреждение "Институт экспериментальной медицины" (ФГБНУ "ИЭМ") Способ уменьшения выраженности немоторных симптомов у пациентов, страдающих болезнью Паркинсона
NL2028324B1 (en) 2021-05-28 2022-12-12 Caelus Pharmaceuticals B V Insulin-sensitizing agent and butyrate-producing bacterium
US12156859B2 (en) * 2021-12-20 2024-12-03 Tainnovation Inc. Methods of and compositions for treating obesity, obesity-related diseases or cancers using a N6-methyllysine/l-lysine mixture
CN116530573B (zh) * 2023-05-15 2025-11-18 北京唯爱生物科技有限公司 一种发酵乳饮及其制备方法
EP4643657A1 (en) * 2024-04-30 2025-11-05 Velocity Life Sciences, LLC Compositions containing short-chain fatty acid, methods of use, and methods of making thereof
US12226383B1 (en) 2024-04-30 2025-02-18 Velocity Life Sciences, LLC Compositions containing short-chain fatty acid, methods of use, and methods of making thereof
CN120570920B (zh) * 2025-05-30 2026-04-10 吉林农业大学 产丁酸肠杆菌作为抗柔嫩艾美耳球虫的益生菌的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8728794B2 (en) * 2004-12-28 2014-05-20 Meiji Seika Pharma Co., Ltd. Strain conferring anti-disease properties to host and bacterial cell composition
KR101982491B1 (ko) 2011-08-30 2019-05-27 아카데미쉬 메디쉬 센트륨 인슐린 저항 예방 및/또는 치료 방법
US20140242654A1 (en) 2013-02-26 2014-08-28 Coskata, Inc. Butyrate Producing Clostridium species, Clostridium pharus
WO2014150094A1 (en) 2013-03-15 2014-09-25 University Of Florida Research Foundation, Inc. Butyrogenic bacteria as probiotics to treat clostridium difficile
KR20170103920A (ko) 2015-01-09 2017-09-13 바게닝겐 유니버시테이트 위장관, 대사성 및/또는 기타 질환의 치료 및/또는 예방을 위한 박테리아-함유 조성물 및 이의 사용 방법

Also Published As

Publication number Publication date
EP3242957A1 (en) 2017-11-15
RU2017126666A (ru) 2019-02-12
CA2973285C (en) 2023-10-17
SG11201705450SA (en) 2017-07-28
US11426436B2 (en) 2022-08-30
EP3242957B1 (en) 2020-03-11
KR20170103920A (ko) 2017-09-13
ES2796355T3 (es) 2020-11-26
CA2973285A1 (en) 2016-07-14
US20210069263A1 (en) 2021-03-11
WO2016110585A1 (en) 2016-07-14
CN107405369A (zh) 2017-11-28
RU2017126666A3 (da) 2019-07-24
AU2016205975A1 (en) 2017-07-27
CN107405369A8 (zh) 2018-01-16
US20180353552A1 (en) 2018-12-13
PL3242957T3 (pl) 2020-10-05
BR112017014649A2 (pt) 2018-03-13
AU2016205975B2 (en) 2021-05-27
US11452746B2 (en) 2022-09-27

Similar Documents

Publication Publication Date Title
DK3242957T3 (da) Bakterieholdige sammensætninger og fremgangsmåder til anvendelse af samme til behandling og/eller forebyggelse af gastrointestinale, metaboliske og/eller andre sygdomme
DK3580561T3 (da) Hla-baserede metoder, sammensætninger og anvendelse heraf
DK3676297T3 (da) Forbindelser, sammensætninger og fremgangsmåder
DK3116997T3 (da) Crispr/cas-relaterede fremgangsmåder og sammensætninger til behandling af lebers kongenitale amaurose 10 (lca10)
DK3207130T3 (da) Sammensætninger af Adenosin Deaminase-2 (ADA2), varianter deraf og fremgangsmåder til anvendelse af samme
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
IL254959B (en) Compositions and methods for non-myeloablative conditioning
DK3407888T3 (da) Pyridopyrroloquinoxalinforbindelser, deres sammensætninger og anvendelser
KR20180084891A (ko) 구조 조성물 및 방법
DK3297637T3 (da) Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf
DK3134130T3 (da) Sammensætninger og fremgangsmåder til behandling af hæmoglobinopatier
LT3549592T (lt) Kompozicijos, apimančios bakterijų kamienus
DK3495023T3 (da) Semifluorerede forbindelser og sammensætninger deraf
DK3161124T3 (da) Endofytter, associerede sammensætninger og fremgangsmåder til anvendelse deraf
DK3204386T3 (da) Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed
DK3143134T3 (da) Modificerede, naturlige dræberceller og anvendelser deraf
DK3155101T3 (da) Sammensætninger og fremgangsmåder til ekspression af CRISPR-leder-RNA´er under anvendelse af H1-promotoren
DK3316909T3 (da) Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder
BR112016018521A2 (pt) composição, e, kit.
DK3557998T3 (da) Sammensætninger, kompositioner og anvendelsesmetoder
DK2924093T3 (da) Multicarboxylat-sammensætninger og fremgangsmåde til fremstilling af disse
DK3102555T3 (da) Sammensætninger af forbindelser og anvendelser deraf
DK3172233T3 (da) Anti-cd74-antistoffer, sammensætninger omfattende anti-cd74- antistoffer og fremgangsmåder til anvendelse af anti-cd74-antistoffer
DK2967049T3 (da) Metoder, forbindelser og sammensætninger til behandlingen af angiotensin relaterede sygdomme
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning